TSR Update: 95% + Alerts Trigger within 6 Sec
Modes: Web, Email, SMS, WhatsApp & Push Notification -
Request For Demo
Request For Demo
TSR Update: 95% + Alerts Within 6 Sec
SMS, WhatsApp... on 1 Min to Qtr Tick Alerts
Request For Demo
Request For Demo
Free Access to TSR Screeners - Sign Up for Your Nightly Pass
EBITDA Analysis of Mangalam Drugs & Organics - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY EBITDA
Period Ending - Mar-25
36.33 Cr
Period Ending - Mar-24
17.50 Cr
Growth
107.60 %
Trailing Twelve Months EBITDA
Period Ending - Mar-25
36.23 Cr
Most recent Quarter EBITDA
Period Ending - Mar-25
10.37 Cr
Period Ending - Dec-24
8.83 Cr
Growth
17.50 %
EBITDA CAGR of MANGALAM
3 Yr CAGR-9.58% | 5 Yr CAGR11.62% | 7 Yr CAGR-2.86% | 10 Yr CAGR5.92% |
EBITDA Analysis of Mangalam Drugs & Organics
| EBITDA of MANGALAM rose handsomely by 107.60 % this year. |
| EBITDA with value of 55.02 Cr was highest in Year Mar-21 in last Five Years. |
| EBITDA with value of 17.50 Cr was lowest in Year Mar-24 in last Five Years. |
| Latest EBITDA with value of 36.33 Cr is lower than Average EBITDA of 36.79 Cr in last five years. |
Other EBITDA Related Info of MANGALAM that may interest you.
Mangalam Drugs & Organics Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MANGALAM | 79.73 | 80.73 | 1.24 % | Drugs & Pharma |
Defination of EBITDA
EBITDA or earnings before interest, taxes, depreciation, and amortization is used to represent cash profit generated by the company's operations. more ..
EBITDA Related Ratios
| Revenue | NetIncome | OpsProfit | EBIT | PAT | PBT |
Tsr Profitability Index
| Very Low Profitability Stock | Screener |
Key Financial Ratios on EBITDA
EBITDA Margin TTM
11.38
Debt To EBITDA
0.254
EV To EBITDA
3.74
FY - Historical EBITDA of Mangalam Drugs & Organics
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| EBITDA | 36.33 Cr | 17.50 Cr | 25.95 Cr | 49.14 Cr | 55.02 Cr | 20.97 Cr | 7.97 Cr |
| Change | 107.60 % | -32.56 % | -47.20 % | -10.67 % | 162.41 % | 163.16 % | -82.10 % |
| Price | 74.30 | 92.10 | 98.00 | 102.40 | 100.15 | 30.45 | 54.60 |
| Price Change | -19.33 % | -6.02 % | -4.30 % | 2.25 % | 228.90 % | -44.23 % | -66.39 % |
FY Chart of EBITDA of Mangalam Drugs & Organics
Quarterly Historical EBITDA of Mangalam Drugs & Organics
| Period | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|---|---|---|
| EBITDA | 10.37 Cr | 8.83 Cr | 8.84 Cr | 8.19 Cr | 11.74 Cr | 6.98 Cr | 11.79 Cr |
| Change | 17.50 % | -0.166 % | 7.93 % | -30.23 % | 68.19 % | -40.80 % | 440.74 % |